LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
"Valerie W. McClain, IBCLC" <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Mon, 22 Oct 2001 19:05:16 EDT
Content-Type:
text/plain
Parts/Attachments:
text/plain (54 lines)
Just ran across this article from July of this year and was impressed.  This 
article discusses the fact that Martek was on the cover of the journal, 
Science, for genetically engineering algae.  I guess we are suppose to 
believe that the algae they put in infant formula isn't genetically 
engineered.  Or are we to understand that the FDA is giving approval for 
genetically engineered DHA for infant formula?  Anyway let me see, how many 
ingredients are genetically engineered in infant formula?  I've lost count.  
You know I wonder how all these ge'd ingredients mix together in a baby's 
stomach?  Maybe the FDA can explain to us the justification for approval of 
this ingredient in infant formula?   Valerie W. McClain, IBCLC
  
http://www.washtech.com/news/biotech/10900-1.html
"It was an FDA decision that pushed Martek Biosciences Corp. of Columbia into 
the top 10 stocks for the quarter. Martek's stock nearly doubled during the 
quarter, opening at $15.50 and closing Friday at $28.50.
The FDA approved the use in baby formula of Martek's pioneer products — two 
nutritional oils that help prevent developmental problems in infants. The 
oils, known by the initials DHA and ARA, occur naturally in breast milk. 
Already used in infant formula sold in other countries, DHA and ARA are 
expected to become widely used here, now that the FDA has ruled they are 
"generally recognized as safe."
Martek has agreements to supply the oil to Mead Johnson, Abbott Laboratories 
and American Home Products Corp., the three biggest makers of formula in the 
United States. Their products utilizing Martek's nutritional supplements are 
expected to be on the market by this fall, offered first in premium products 
that cost 10 percent to 15 percent more than standard formula.
Martek's controller, Tom Feeley, said that because of the FDA decision, 
Martek's revenue is projected to double, to $35 million to $40 million next 
year from $18 million to $20 million this fiscal year. The company projects a 
loss of about $12 million in the fiscal year ending in October, but it hopes 
to be profitable by the end of the following year.
Though Martek's oils occur naturally in breast milk, the company makes its 
commercial versions from algae.
Manufacturing products from algae is Martek's specialty. Last month, the 
company made the cover of the journal Science with its breakthrough 
technology using genetically-engineered algae.
Martek scientists took an algae that ordinarily demands light to grow — like 
plain old pond scum — and tinkered with its genes so it could grow in total 
darkness, drawing its energy from sugars.
Algae that need light have to be grown in what amount to high-tech ponds, 
under intense illumination. But if those same algae can be reengineered to 
prosper without light, they can be grown in simple tanks, a far cheaper 
production technology."
    

    
    

             ***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html

ATOM RSS1 RSS2